Showing results (41-50 of 48) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
European Journal of Nuclear Medicine|October 1, 1994
Dose escalation study of rhenium-186 hydroxyethylidene diphosphonate in patients with metastatic prostate cancerJ M de Klerk, B A Zonnenberg, A D van het Schip, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 1, 1996
Transient cranial neuropathy in prostatic cancer with bone metastases after rhenium-186-HEDP treatmentJ M de Klerk, B A Zonnenberg, H G Krouwer, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 1, 1994
Evaluation of thrombocytopenia in patients treated with rhenium-186-HEDP: guidelines for individual dosage recommendationsJ M de Klerk, A D van het Schip, B A Zonnenberg, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 21, 1999
186Re-etidronate in breast cancer patients with metastatic bone painS H Han, B A Zonneberg, J M de Klerk, et al.Anticancer Research|May 1, 1997
Treatment of metastatic bone pain using the bone seeking radiopharmaceutical Re-186-HEDPJ M De Klerk, B A Zonnenberg, G H Blijham, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 1, 1997
Iodine-131 therapy in sporadic nontoxic goiterJ M de Klerk, J W van Isselt, A van Dijk, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 1, 1996
Bone marrow absorbed dose of rhenium-186-HEDP and the relationship with decreased platelet countsJ M de Klerk, E B van Dieren, A D van het Schip, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 1, 1996
Efficacy of rhenium-186-etidronate in prostate cancer patients with metastatic bone painJ M Quirijnen, S H Han, B A Zonnenberg, et al.Pageof 5